Research Achievements
Ichiro Yoshino| 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Alaa M‚ Suzuki M‚ Yoshino M‚ Tian L‚ Suzuki H‚ Nagato K‚ Fujiwara T‚ Wada H‚ Moriya Y‚ Hoshino H‚ Motohashi S‚ Yoshida S‚ Shibuya K‚ Hiroshima K‚ Nakatani Y‚ Abdrabou A‚ Elkholy M‚ Mahfouz T‚ Yoshino I. Prostaglandin E2 receptor 2 overexpression in squamous cell carcinoma of the lung correlates with p16INK4A methylation and an unfavorable prognosis.
Int J Oncol. 2009; 34 (3): 805-812
International Conferences
Yoshino M‚ Suzuki M‚ Moriya Y‚ Hoshino H‚ Motoahashi S‚ Yoshida S‚ Shibuya K‚ Yoshino I. Promoter hypermethylation of p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers
13th World Conference on Lung Cancer 2009-9-28 San Francisco/U.S.A.
Motohashi S‚ Nagato K‚ Taniguchi M‚ Nakayama T‚ Yoshino I. ¦Á-Galactosylceramide-pulsed antigen presenting cell treatment in patients with advanced NSCLC
13th World Conference on Lung Cancer 2009-7-31 San Francisco/U.S.A.
Nagato‚ K.‚ Motohashi‚ S.‚ Yoshino‚ I.‚ Taniguchi‚ M.‚ and Nakayama‚ T. Accumulation of activated V¦Á24 invariant natural killer T cells in the tumor microenvironment after ¦Á-Galactosylceramide-pulsed antigen presenting cell treatment.
The 5th International Symposium on CD1/NKT cells 2009-3-23 Kamakura/Japan
